Seeking Alpha

Available Nationwide: JUVÉDERM® VOLUMA® XC for Moderate to Severe Temple Hollowing

Oct 02, 2024, 8:00 AM ETAbbVie Inc. (ABBV) Per FDA requirement for this indication, Allergan Aesthetics is providing a product training program for providers, which includes facial anatomy and ...
Seeking Alpha

Allergan Aesthetics Announces First Ever JUVÉDERM® Day

IRVINE, Calif., Aug. 1, 2023 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the first ever JUVÉDERM ® Day on Wednesday, August 16, 2023. The celebration recognizes the ...
Nasdaq

Get Ready, JUVÉDERM® Day is Calling!

Allergan Aesthetics Celebrates Third Annual JUVÉDERM® Day with BOGO Gift Cards and $10,000 Sweepstakes Join Allē Today to Take Advantage of Limited-Time Offers, While Supplies Last "JUVÉDERM® Day is ...
Monthly Prescribing Reference

Juvederm Volbella XC Approved for Perioral Rhytids

Perioral Rhytids Allergan announced that the Food and Drug Administration (FDA) has approved Juvederm Volbella XC for use in lip augmentation and for correction of perioral rhytids (referred to as ...

Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (HA) Injectables with JUVÉDERM® at AMWC Monaco

Allergan Aesthetics, an AbbVie company, a global leader in medical aesthetics treatments and manufacturers of the market-leading JUVÉDERM® Collection of Fillers,3,4,‖ is once again forging ahead and ...
Healio

FDA warns of unapproved versions of Juvéderm

Please provide your email address to receive an email when new articles are posted on . The FDA announced it has updated its dermal fillers website to include a ...
Monthly Prescribing Reference

Juvederm Vollure XC Approved for Facial Wrinkles and Folds

The injectable gel is balanced with firmness and low cohesivity delivering results that last up to 18 months from the initial or touch-up injection. Allergan announced that the Food and Drug ...
Business Wire

ADDING MULTIMEDIA FDA Approves JUVÉDERM VOLUMA™ XC

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE:AGN) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLUMA™ XC, the ...
Business Wire

Allergan, Inc. Announces Nationwide Availability of JUVÉDERM™ ULTRA and JUVÉDERM™ ULTRA PLUS Dermal Fillers

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE:AGN), the maker of BOTOX ® Cosmetic (Botulinum Toxin Type A), today announced nationwide availability of its ‘next-generation’ hyaluronic acid ...
Business Insider

Allergan Aesthetics Celebrates 100 Million Syringes of JUVÉDERM®

JUVÉDERM ® Collection of Fillers Continues Position as the World's Number One Chosen Dermal Filler Collection IRVINE, Calif., Sept. 7, 2022 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie ...
FiercePharma

U.S. FDA Approves JUVEDERM® ULTRA XC for Use in Lips

First and Only Filler Approved for Lip Augmentation that Lasts Up to One Year DUBLIN, Oct. 1, 2015 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced ...